https://wsxzaq.shinyapps.io/wsxzaq_nomogram/). The score has been verified among three independent external cohorts (GSE13213, GSE68465 and GSE72094), and is still an independent risk factor for lung adenocarcinoma. In addition, among the other 6 cancers, the OS prognosis of high and low-risk groups of PRS is different (P < 0.05). Our research results have screened multiple platelet differential genes with clinical significance and constructed a meaningful prognostic risk score (PRS)." name="description"> Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression - Figure f6 | Aging
← Back
Research Paper Volume 13, Issue 6 pp 8706—8719

Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression

class="figure-viewer-img"

Figure 6. External data support. (A) Protein Expression of Risk Score Components in TCPA Database. (B) Immunohistochemical Results of Risk Score Components in HPA Database. (C) The relationship between PRS and TP53 mutations and KRAS mutations on GSE13213.